800.644.5687
Request a Quote
|
Ordering
|
Explore our Panels
Search for:
Target Classes
Explore Our Panels
Overview
Bromodomains
GPCRs
All GPCR Assays
Known
Orphan
Ortholog
Kinases
Biochemical Assays
Cell-based Kinase Portfolio
Pathways
NHRs
Services
Overview
BROMOscan
Screening & Profiling
Panel Services
Cell-based Kinase Panel
Full GPCR Panel
Orphan GPCR Panel
NHR Panel
Therapeutic GPCR Panels
High Throughput Screening
Contract Services
Technology
Competition Binding Platform
BROMOscan Epigenetic Assay
KINOMEscan Kinase Assay
GPCRs
Arrestin
Internalization
Second Messenger
Kinases
NHRs
Pathways
How it Works
Benefits
FAQ
Applications
Overview
Lead Discovery/Library Screening
Lead Optimization
Compound Safety
Tools & Resources
Webinars
Compound Submission
Panel Screening Schedule
Study Reports & Data Analysis
Publications
Document Resource Library
Publication List
Contact Us
Ordering
Partnerships & Alliances
Sales Contact
Services
>
High Throughput Screening
Overview
BROMOscan
Screening & Profiling
Panel Services
High Throughput Screening
Contract Services
High Throughput Screening Services
Enjoy the convenience of outsourced high-throughput screening and ready access to a portfolio of more than 600 highly validated and robust assays that can be deployed for testing against compound collections of any size. Outsource with confidence knowing that DiscoveRx's assays are performed under highly standardized conditions using best-in-class lab automation to provide exceptional assay performance and reproducible data. Save time and resources by eliminating assay development and free up internal resources to focus on other high value discovery activities.
From single target HTS to library profiling and follow-up services, DiscoveRx has the experience, capacity and capability to rapidly and reliably deliver accurate, precise and reproducible data that ensures project timelines are met and maximizes the discovery of potent & selective lead compounds for new drug discovery programs.
Benefits
Select from over 600 validated assays across multiple target classes
Capacity to screen more than 50,000 wells/day
Confirmation services available using multiple readouts
Identify novel chemotypes using multiple readouts for the same target
Accurate, precise & reproducible data
Free internal resources to focus on other activities
Selectivity services available for determining specificity and off target activity
Assay Validation & Data Uniformity
Vehicle tolerance is determined as part of the assay validation process prior to every screen [click graph to enlarge].
Plate uniformity data for a typical screen run in antagonist mode. Results show excellent performance with an average Z’ of 0.7, 47% inhibition for control antagonist IC50, and overall hit rate of 1.5% [click graph to enlarge].
Explore Our Panels
Browse Panels
and Assays
Request a Quote
Online Quote
Request
Therapeutic Panels
Cancer
Cardiovascular
Chemokine
Digestive & Renal
Inflammation
Metabolic
Neurological
Psychiatric
Reproduction
Respiratory
Sensory